Hoxton Planning & Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Hoxton Planning & Management's PFE Position: Q3 2026 in Review
Hoxton Planning & Management reduced its Pfizer (PFE) stake by 5.5% in Q3 2026, selling an estimated $39.5K and leaving 25,423 shares worth $725K. The position accounts for 0.18% of the portfolio, ranked #88.
Hoxton Planning & Management first reported a position in PFE in Q4 2022 and has held it in 16 quarters since. The position peaked at $826K in Q4 2024. 699 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Hoxton Planning & Management held 25,423 shares of Pfizer worth $725K as of Q3 2026.
- Hoxton Planning & Management sold 1,484 Pfizer shares in Q3 2026, an estimated $39.5K.
- Pfizer made up 0.18% of Hoxton Planning & Management's portfolio in Q3 2026, its #88 holding.
- Hoxton Planning & Management first reported a position in Pfizer in Q4 2022 and has held it in 16 quarters since.
- Hoxton Planning & Management's Pfizer position peaked at $826K in Q4 2024.
- 699 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Hoxton Planning & Management's 13F filing for Q3 2026, filed 15 Oct 2026.